Literature DB >> 12631119

Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice.

Veerle P Persy1, Anja Verhulst, Dirk K Ysebaert, Kathleen E De Greef, Marc E De Broe.   

Abstract

BACKGROUND: Osteopontin (OPN) is a phosphoprotein that is up-regulated in several experimental models of renal disease, including ischemia/reperfusion injury. OPN has been described as a macrophage chemoattractant, may serve as a survival factor for tubular cells, and is implicated in the development of tubulointerstitial fibrosis. However, the precise role of this protein in renal pathophysiology remains unclear.
METHODS: OPN knockout and wild-type mice were subjected to 30 minutes of warm renal ischemia combined with a contralateral nephrectomy, and sacrificed at six different time points, ranging from 12 hours to seven days after reperfusion. Besides functional and morphological parameters of postischemic acute renal failure (ARF), macrophage infiltration, apoptosis and expression of collagen types I and IV were investigated.
RESULTS: Postischemic ARF in OPN knockouts and wild-types showed a similar course and severity, without significant differences in either functional or morphological disease parameters. However, macrophage infiltration was significantly diminished in OPN knockouts after five and seven days, in cortex as well as in the outer stripe of the outer medulla (OSOM). Furthermore, OPN knockout mice showed significantly enhanced apoptosis in the injury phase and significantly less collagen I and IV expression in the regeneration phase of postischemic ARF.
CONCLUSIONS: There was no influence of OPN protein on the severity or course of functional impairment or morphological injury in the first seven days after an ischemic insult to the kidney. However, our results demonstrate that OPN favors macrophage recruitment to the postischemic kidney, inhibits apoptosis, and stimulates the development of renal fibrosis after an acute ischemic insult.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12631119     DOI: 10.1046/j.1523-1755.2003.00767.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  48 in total

1.  Overexpression of cGMP-dependent protein kinase I (PKG-I) attenuates ischemia-reperfusion-induced kidney injury.

Authors:  Yanzhang Li; Xiaopeng Tong; Hasiyeti Maimaitiyiming; Kate Clemons; Ji-Min Cao; Shuxia Wang
Journal:  Am J Physiol Renal Physiol       Date:  2011-12-07

2.  Osteopontin reduced hypoxia-ischemia neonatal brain injury by suppression of apoptosis in a rat pup model.

Authors:  Wanqiu Chen; Qingyi Ma; Hidenori Suzuki; Richard Hartman; Jiping Tang; John H Zhang
Journal:  Stroke       Date:  2011-01-27       Impact factor: 7.914

3.  The role of osteopontin and osteopontin aptamer (OPN-R3) in fibroblast activity.

Authors:  Cedric Hunter; Jennifer Bond; Paul C Kuo; Maria Angelica Selim; Howard Levinson
Journal:  J Surg Res       Date:  2011-08-27       Impact factor: 2.192

Review 4.  Engineering biomaterials to integrate and heal: the biocompatibility paradigm shifts.

Authors:  James D Bryers; Cecilia M Giachelli; Buddy D Ratner
Journal:  Biotechnol Bioeng       Date:  2012-05-24       Impact factor: 4.530

5.  Regulation of Cellular Redox Signaling by Matricellular Proteins in Vascular Biology, Immunology, and Cancer.

Authors:  David D Roberts; Sukhbir Kaur; Jeffrey S Isenberg
Journal:  Antioxid Redox Signal       Date:  2017-09-08       Impact factor: 8.401

6.  Chemokine receptor CCR1 regulates inflammatory cell infiltration after renal ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Richard Horuk; Takashi Wada; Shuichi Kaneko; Philip M Murphy
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

7.  Chemokine receptor CX3CR1 regulates renal interstitial fibrosis after ischemia-reperfusion injury.

Authors:  Kengo Furuichi; Ji-Liang Gao; Philip M Murphy
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

8.  Soluble thrombomodulin protects ischemic kidneys.

Authors:  Asif A Sharfuddin; Ruben M Sandoval; David T Berg; Grant E McDougal; Silvia B Campos; Carrie L Phillips; Bryan E Jones; Akanksha Gupta; Brian W Grinnell; Bruce A Molitoris
Journal:  J Am Soc Nephrol       Date:  2009-01-28       Impact factor: 10.121

9.  Osteopontin and Disease Activity in Patients with Recent-onset Systemic Lupus Erythematosus: Results from the SLICC Inception Cohort.

Authors:  Lina Wirestam; Helena Enocsson; Thomas Skogh; Leonid Padyukov; Andreas Jönsen; Murray B Urowitz; Dafna D Gladman; Juanita Romero-Diaz; Sang-Cheol Bae; Paul R Fortin; Jorge Sanchez-Guerrero; Ann E Clarke; Sasha Bernatsky; Caroline Gordon; John G Hanly; Daniel Wallace; David A Isenberg; Anisur Rahman; Joan Merrill; Ellen Ginzler; Graciela S Alarcón; W Winn Chatham; Michelle Petri; Munther Khamashta; Cynthia Aranow; Meggan Mackay; Mary Anne Dooley; Susan Manzi; Rosalind Ramsey-Goldman; Ola Nived; Kristjan Steinsson; Asad Zoma; Guillermo Ruiz-Irastorza; Sam Lim; Ken Kalunian; Murat Inanc; Ronald van Vollenhoven; Manuel Ramos-Casals; Diane L Kamen; Søren Jacobsen; Christine Peschken; Anca Askanase; Thomas Stoll; Ian N Bruce; Jonas Wetterö; Christopher Sjöwall
Journal:  J Rheumatol       Date:  2019-01-15       Impact factor: 4.666

Review 10.  The divergent roles of macrophages in solid organ transplantation.

Authors:  Sahar Salehi; Elaine F Reed
Journal:  Curr Opin Organ Transplant       Date:  2015-08       Impact factor: 2.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.